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Autosomal dominant polycystic kidney disease is
a common form of inherited kidney disease that
is caused bymutations in two genes, PKD1 (polycys-
tin-1) and PKD2 (polycystin-2). Mice with germline
deletion of either gene die in midgestation with a
vascular phenotype that includes profound edema.
Although an endothelial cell defect has been sus-
pected, the basis of this phenotype remains poorly
understood. Here, we demonstrate that edema in
Pkd1- and Pkd2-null mice is likely to be caused by
defects in lymphatic development. Pkd1 and Pkd2
mutant embryos exhibit reduced lymphatic vessel
density and vascular branching along with aberrant
migration of early lymphatic endothelial cell precur-
sors. We used cell-based assays to confirm that
PKD1- and PKD2-depleted endothelial cells have
an intrinsic defect in directional migration that is
associated with a failure to establish front-rear polar-
ity. Our studies reveal a role for polycystin signaling
in lymphatic development.INTRODUCTION
Mutations in two genes, PKD1 and PKD2, result in autosomal
dominant polycystic kidney disease (ADPKD), a common cause
of renal failure in humans (Harris and Torres, 2009). Polycystin-1
(PC1) is a large membrane receptor with a short intracellular C
terminus that binds to polycystin-2 (PC2), which has homology
to the transient receptor potential family of calcium-permeable
cation channels (Gallagher et al., 2010). Together, PC1 and
PC2 are thought to form a receptor channel complex that medi-
ates calcium-based signaling pathways. The upstream and
downstream members of this signaling cascade remain obscure
despite years of intense investigation.634 Cell Reports 7, 634–644, May 8, 2014 ª2014 The AuthorsAlthough PC1 and PC2 are broadly expressed, the phenotype
associated with human ADPKD is relatively restricted to cyst
formation in epithelium-lined tubes in the liver and kidney. Cysts
arising from renal and biliary epithelial cells are thought to derive
primarily via a two-hit mechanism whereby somatic mutation of
the wild-type PKD allele results in loss of PC signaling (Pei et al.,
1999; Qian et al., 1996; Watnick et al., 1998). However, less
frequent PKD manifestations, such as intracranial aneurysms,
hint that PCs may have broader functions outside renal and
biliary epithelial cells (Chapman et al., 1992; Pirson, 2010). This
is more clearly revealed by Pkd1 and Pkd2 knockout mice that
die in midgestation with a variety of phenotypes, including a
vasculopathy that is characterized by profound edema (Boulter
et al., 2001; Kim et al., 2000; Wu et al., 2000). Since mice with
targetedmutations in genes that are involved in proper lymphatic
patterning, such as Prox1 and Vegfc, exhibit edema reminiscent
of what has been described in Pkd-null embryos, we hypo-
thesized that lymphatic development might also be defective in
Pkd mutant animals (Karkkainen et al., 2004; Wigle and Oliver,
1999). Here, we show that both Pkd1- and Pkd2-null embryos
have aberrant lymphatic vessel formation with decreased vessel
sprouting and abnormalities in the migratory pattern of early
lymphatic precursors. We also demonstrate that both Pkd1-
and Pkd2-depleted endothelial cells (ECs) have an intrinsic
defect in directed migration that likely contributes to the in vivo
phenotype. Our work establishes a role for PCs in lymphatic
development and identifies a signaling pathway that is involved
in lymphangiogenesis.
RESULTS
Edema and Cardiac Defects Can Be Dissociated in Pkd
Mutant Embryos
Edema is a universal feature of all Pkd1- and Pkd2-null animals
reported in the literature to date, and has been variably attributed
to vascular fragility and/or cardiac pathology (Arnaout, 2000). In
order to rigorously investigate the relationship between edema
and cardiac defects, we used microcomputed tomography
(micro-CT) to visualize cardiac structures in embryonic day
Figure 1. Cardiac Structures in E14.5
Embryos
(A–H) Representativemicro-CT images of Pkd1/
and Pkd1control hearts. Axial sections and sagittal
sections highlight cardiac structures. LA, left
atrium; LV, left ventricle; RA, right atrium; RV, right
ventricle; Ao, aorta; PV, pulmonary vein; PA, pul-
monary artery; IVS, interventricular septum; LL,
left lung; RL, right lung. Scale bars represent
0.5 mm.
(I and J) Representative 3D segmentation images.
Scale bars represent 0.5 mm.
(K and L), Representative H&E-stained cardiac
sections. Scale bar represents 250 mm.
(M) Quantification of heart wall thickness at
defined areas in n = 4Pkd1/ and n = 3 Pkd1control
hearts. Results are presented as the mean ± SEM.
NS, not significant.14.5 (E14.5) Pkd1/ embryos (n = 3) and controls (n = 3; Fig-
ure 1). Each of the Pkd1 mutant embryos had obvious edema
but lacked structural heart defects (e.g., conotruncal defects)
that have been described in some mouse models (Figures
1A–1J; Boulter et al., 2001; Wu et al., 2000). We also measured
heart wall thickness in defined areas and were unable to detect
any statistically significant differences (Figures 1K–1M). These
findings suggest that edema does not depend on the presence
of developmental cardiac defects and is likely due to other
factors.
Pkd1- and Pkd2-Null Embryos Exhibit Edema with
Cutaneous Lymphatic Vessel Defects
Since the lymphatic system plays a critical role in tissue fluid
homeostasis, we speculated that a defect in the lymphatic
vasculature might be the primary cause of edema in Pkdmutant
embryos. This was plausible since both PC1 and PC2 could be
detected by western analysis in cultured human lymphatic endo-
thelial cells (LECs) as well as in LECs isolated from the skin of
wild-type mouse embryos at E15.5 (Figure 2A).
We defined the time course of subcutaneous edema formation
in Pkd/ embryos and confirmed that edema was barely visible
at E12.5 but became severe by E14.5 (Figures 2B–2D and S1A–
S1C). By E14.5, a superficial capillary lymphatic network is
present in mice and is thought to derive from the jugular
lymphatic sac (JLS) and possibly other venous vessels by a
process that involves angiogenesis and then further remodeling
(Ha¨gerling et al., 2013; Wigle and Oliver, 1999; Yang et al., 2012).Cell Reports 7, 634We harvested E14.5 embryos and per-
formed whole-mount staining of dorsal
skin with antisera to Endomucin and
lymphatic vessel endothelial receptor-1
(Lyve1), which identify blood venous
ECs and LECs, respectively (Banerji
et al., 1999; Ha¨gerling et al., 2013).
Control embryos had a highly branched
network of lymphatic vessels that were
sprouting toward the midline by E14.5
(Figures 2E and 2H). In contrast bothPkd1/ and Pkd2/ mice exhibited a grossly disorganized
and distended lymphatic capillary tree (Figures 2F, 2G, 2I, and
2J). Quantification revealed that both Pkd1 and Pkd2 mutants
had a significantly reduced number of lymphatic vessels along
with a larger average vessel diameter (Figures 2K and 2L). The
complexity of the lymphatic vessel network in the Pkd1 and
Pkd2 mutants was decreased, with significantly fewer branch
points and a reduction in filopodia formation, which is required
for sprouting and lymphatic outgrowth (Figures 2M and S1D–
S1G). In addition, we observed that in Pkd1- and Pkd2-null
embryos, cutaneous lymphatics were often filled with red blood
cells (Figures S1H–S1J). This was also evident upon gross in-
spection (Figure S1H).
LEC Network Formation Is Decreased by Knockdown
of PCs
In order to determine whether PCs are required for capillary
network formation, we used an in vitro endothelial tube formation
assay (Kazenwadel et al., 2012). We transduced primary human
microvascular LECs as well as human umbilical vein ECs
(HUVECs) with lentivirus carrying empty vector or small hairpin
RNAs (shRNAs) directed at PKD1 or PKD2. We assayed the
ability of these cells to form a capillary matrix when seeded on
Matrigel in the presence of vascular endothelial growth factor
C (VEGF-C; Figures 2N–2Q and S1K–S1N). We found that in
comparison with controls, PKD1- or PKD2-depleted ECs were
less effective at forming capillary networks with significantly
fewer capillary-like structures and fewer branch points (Figures–644, May 8, 2014 ª2014 The Authors 635
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2P and 2Q, S1M, and S1N). This is similar to the phenotype that
we observed in the skin of Pkd1 and Pkd2 mutant embryos.
Lymphatic Precursors Migrate Aberrantly in Pkd1 and
Pkd2 Mutant Embryos
A series of seminal studies have now clearly confirmed that the
lymphatic vasculature is of venous origin (Srinivasan et al.,
2007). Lymphatic specification in mice begins at E9.5 when a
restricted population of ECs on one side of each anterior cardinal
vein is induced to express the homeobox transcription factor,
Prox1 (Wigle and Oliver, 1999). Prox1+ lymphatic EC precursors,
stimulated by VEGF-C in the surrounding mesenchyme, then
delaminate from the cardinal veins at E10.5–12.5 and migrate
along a specific dorsolateral pathway to form the primary lymph
sacs, which lie in close proximity to the cardinal veins (Karkkai-
nen et al., 2004; Wigle and Oliver, 1999).
Since the onset of edema in Pkd mutant animals appeared to
be contemporaneous with formation of the first lymphatic
vessels, we wondered whether the early steps of lymphangio-
genesis occurred normally in these animals.We generated trans-
verse sections in the jugular region of E11.5 Pkd1/ and
Pkd2/ embryos and their littermate controls, and stained
with antisera to Endomucin and Prox1 (Figures 3A–3E). As
expected at this developmental stage, Prox1+ LECs were
budding from the dorsolateral aspect of the cardinal vein in
control embryos (Figures 3A and 3C). Although LECs were also
migrating away from the cardinal vein in mutant embryos, the
distribution pattern of these cells was different in comparison
with controls (Figures 3B and 3D). In control embryos, LECs
were found in a narrow, restricted dorsolateral area, as has
been previously described (Figures 3A and 3C; Karkkainen
et al., 2004; Wigle and Oliver, 1999). In contrast, in both Pkd1/
and Pkd2/ embryos, the distribution of Prox1+ cells appeared
to be more random (Figures 3B and 3D). Prox1+ cells were more
widely dispersed and we frequently saw these early LECs on the
opposite side of the cardinal vein. We quantified the area of
distribution of Prox1+ cells in the dorsolateral aspect of the
cardinal vein and found it to be significantly increased in both
Pkd1/ and Pkd2/ mutant embryos (Figure 3F). The total
number of Prox1-expressing cells, however, was no different
between the genotypes (Figure 3G). These data suggest that
loss of Pkd1 or Pkd2 impairs the ability of LECs to migrate in a
directed fashion.
We sought to determine whether the altered migration pattern
that we observed at E11.5 would affect subsequent jugularFigure 2. Cutaneous Lymphatic Vessels Defects in E14.5 Pkd1- and Pk
(A) Western blot from ECs probed with antibodies to PC1 and PC2. hLECs, prim
(B–D) Representative E14.5 embryos. Arrowheads indicate edema and asterisks
(E–J) Whole mount of dorsal skin from E14.5 embryos stained with antisera to Ly
scopic fields (2 mm 3 2 mm). Scale bars represent 250 mm.
(H–J) Enlarged views of boxed areas in panels (E)–(G). Scale bar represents 50 m
(K–M) Quantification of E14.5 dermal Lyve1+ lymphatic vessel numbers (K), diam
(N) Tube formation assay using hLECs expressing lentiviral shRNAs directed a
Capillary structures are stained with Phalloidin (green). Red asterisks indicate br
(O) Western blots prepared from hLECs transfected with lentiviral shRNAs and p
(P and Q) Quantification of Phalloidin-stained capillary structures (P) and branch
pendent experiments, repeated in triplicate. Results in (K)–(M), (P), and (Q) are p
See also Figure S1.lymph sac (JLS) formation.We sectioned E14.5 embryos at three
distinct thoracic levels (Figure S2A) and stained with Endomucin
and Lyve1. In E14.5 control embryos, we could easily identify
Lyve1-stained lymphatic sacs in close proximity to the cardinal
vein (Figures 3H and 3J, S2B, and S2C). Lymphatic sacs were
also present in Pkd2/ embryos, indicating that despite aber-
rant migration at the earlier time point, the JLS was able to
form (Figures 3I and 3K). In addition, although lymphovenous
valves were present in the mutants, the JLS was frequently
observed to contain red blood cells, which could be consistent
with a functional defect (Figures 3L–3N).
Next, we used computerized morphometry to quantify the
lymphatic sac area in three independent locations (Figures 3O–
3R and S2A). We found that despite the presence of interstitial
edema, the JLS tended to be smaller in Pkd2 mutants, though
this did not reach statistical significance (Figure 3O). We also
noticed that the diameter of the JLS tended to be more variable
in Pkd mutants depending on the level that was analyzed (Fig-
ure S2). This was confirmed on 3D reconstruction of the vascular
structures at E14.5 (Figures S2J and S2K). There was no differ-
ence in the size of other vessels, including the carotid artery
and cardinal vein, between mutant embryos and controls (Fig-
ures 3P, 3Q, S2G, and S2H).
PKD1- and PKD2-Depleted ECs Exhibit Defects in
Directed Migration
Formation of the JLS requires stereotypical dorsolateral migra-
tion of LEC precursors away from the cardinal vein. Since
Prox1+ LECs in Pkd mutant animals at E11.5 were more
dispersed compared with wild-type controls, we speculated
that Pkd1 and Pkd2 might be required for directed LEC migra-
tion. We used primary adult microvascular human lung LECs to
explore the role of PKD1 and PKD2 in cell migration in vitro.
We were able to knock down expression of either PC1 or PC2
effectively using lentiviral vectors with two independent shRNAs
directed at each gene (Figure 2O). Both PC1- and PC2-depleted
LECs migrated more slowly in wound-healing assays compared
with controls (Figures 4A and 4B). At 20 hr after wounding of a
confluent monolayer, ECs transduced with empty vector were
able to close 25% of the wound. In contrast, PC-depleted
ECs were only able to close 12% of the wound. This was not
due to differences in cell proliferation (Figure 4C). We also saw
no significant difference in the total levels of VEGF-C receptor
(VEGF receptor 3 [VEGFR3]) or in phosphorylated VEGFR3 in
the PC-depleted cells versus controls (Figures S3A and S3B).d2-Null Embryos
ary human microvascular LECs; mLECs, primary mouse LECs.
show blood-filled dermal lymphatics. Scale bar represents 1 mm.
ve1 (green) and Endomucin (red). Panels (E)–(G) are montages of nine micro-
m.
eters (L), and branch points (M).
t PKD1 (20DPC1 or 22DPC1), PKD2 (16DPC2 or 17DPC2), or vector control.
anch points. Scale bars represent 200 mm.
robed with antibodies to PC1, PC2, or actin as a loading control.
points (Q). Quantification was performed from three fields/well in n = 4 inde-
resented as the mean ± SEM; **p < 0.01, ***p < 0.001.
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Boyden chamber assays using 200 ng/ml VEGF-C confirmed
that PC1- and PC2-deficient LECs had decreased migration
rates (Figure 4D).
In order to characterize the migratory phenotype of PC-
depleted LECs in more detail, we tracked single cells in
wound-healing assays with time-lapse video microscopy (Fig-
ures 4E–4H). Analysis of the trajectory of individual cells showed
that the accumulated distance traveled by PC-depleted ECs did
not differ from that traveled by controls (Figure 4F). However, the
Euclidean distance was significantly reduced because the
trajectory of these cells was more random (Figure 4G; Movies
S1 and S2). Although there was no difference in the total or
accumulated distance traveled by PC-depleted LECs, the
percentage of these cells that traveled more than 25 mm in the
forward direction was significantly reduced compared with
controls (control: 59%; PC1: 23% and 31%, p < 0.05;
PC2: 13% and 20%, p < 0.001; Figure 4E). This was also
reflected in a decreased directionality index that was calculated
by comparing the Euclidean distance to the accumulated dis-
tance (Figure 4H).
One cardinal feature of directional cell migration is the estab-
lishment of front-rear polarity, which is manifested by reorienta-
tion of the Golgi apparatus in front of the nucleus and along the
axis of migration (Etienne-Manneville and Hall, 2001, 2003;
Ridley et al., 2003). We wounded LEC monolayers and allowed
the cells to migrate for 5 hr, and then stained them with antisera
to the Golgi marker GM130 (Figures 4I–4K). We quantified the
percentage of cells at the front of the wound that were able
to position their Golgi in the forward-facing 120 sector (Fig-
ure 4K). Whereas 62.1% ± 1.2% of control cells were able to
orient their Golgi toward the wound, only 38% ± 0.1% and
38.5% ± 1% of PC1- and PC2-depleted ECs, respectively,
were able to polarize in this fashion (p = 0.002 and p =
0.0001, respectively).
We repeated the in vitro assays in a HUVEC-derived immortal-
ized EC line, EA.hy926, and found similar defects in cell migra-
tion (Edgell et al., 1983; Figure S4; Movies S3 and S4).
Do PCs Have a Generalizable Role in ECs?
Our assays revealed that PC-depleted HUVECs and LECs have
a similar phenotype, raising the possibility that generalizedFigure 3. Distribution of Budding Prox1+ Cells and JLS Development in
(A–D) Transverse jugular sections at E11.5 were stained with DAPI (blue) and antis
was observed in a group of LECs migrating dorsolaterally into the mesenchyme
stain with antisera to Prox1 and Endomucin. Scale bars represent 50 mm.
(E) Schematic showing the three levels of the jugular region that were analyzed i
(F) Quantification of dorsolateral budding area (white dotted line) normalized to t
(G) Quantification of total number of Prox1+ cells/field. Analysis was performed u
(H and I) Representative H&E-stained right and left transverse sections of E14.5 em
the JLS, which is located dorsolaterally. Scale bars represent 200 mm.
(J and K) Transverse sections from the animals shown in (H) and (I), respectively.
arrows, JLS. Scale bars represent 100 mm.
(L) Immunofluorescence showing red blood cells within the JLS (arrowheads) of
(M and N) Representative sections stained with antisera to Endomucin (white) and
the CV. Inset shows enlarged view of the valves. Scale bars represent 10 mm.
(O–R) Quantification of vessel areas as indicated in four sections per jugular are
mean ± SEM; *p < 0.05, **p < 0.01, ***p < 0.001; NS, not significant.
See also Figure S2.defects in vascular networks might contribute to edema for-
mation. We therefore analyzed Endomucin-positive dermal
capillaries in Pkd2/ embryos, and found that there was a
statistically significant decrease in vessel density and branch-
ing compared with controls (Figures 5A–5I). We detected a
similar, albeit milder, defect in embryos with selective EC
deletion of Pkd2 (Pkd2cond/cond; Tie2-Cre+ aka Pkd2endo; Fig-
ures 5C and 5G–5I). We previously demonstrated that Tie2-
Cre-mediated deletion of Pkd1 or Pkd2 in ECs only partially
recapitulates the vascular phenotype observed in null animals
(Garcia-Gonzalez et al., 2010). Specifically, Pkd2endo embryos
lack detectable edema, and when we analyzed the lymphatic
vessels in these mice at E14.5, we found no difference in com-
parison with controls (Figure S5). This is somewhat surprising
since prior lineage-tracing studies demonstrated that this
Tie2-Cre recombinase is active in at least a subset of Prox1+
LEC precursors (Srinivasan et al., 2007). In order to test for
Tie2-Cre-mediated deletion in our model, we used a double-
fluorescent reporter mouse (mT/mG) that expresses enhanced
GFP (EGFP) after recombination (Muzumdar et al., 2007). We
saw little Tie2-Cre recombinase activity in dermal LECs at
E14.5 as indicated by persistent colocalization of Lyve1 and
membrane Tomato (mTomato; Figures 5J and 5K). However,
there was loss of mTomato and activation of EGFP in nonlym-
phatic vessels (Figure 5J). There was only patchy Cre recombi-
nase activity in LECs lining the JLS at E14.5 and E16.5
(Figure S6).
DISCUSSION
The lymphatic vascular network in vertebrates derives from
the venous system in a coordinated morphogenic process
that includes cell fate specification, differentiation, and directed
migration. Our studies reveal an unexpected role for PKD1
and PKD2, the genes that are mutated in ADPKD, in this
process. Here, we show that edema in Pkd mutant mice is
associated with an abnormality in cutaneous lymphatics that
is characterized by diminished complexity of the lymphatic
capillary network, with a defect in vessel branching and filopo-
dia formation. Interestingly, this is similar to the vascular defect
that we previously observed in the fetal placenta of mice withPkd-Null Embryos
era to Prox1 (red) and Endomucin (green). CV, cardinal vein. Prox1 expression
(delineated by the white dotted line). Arrowheads indicate erythrocytes, which
n (A)–(D).
he number of Prox1+ cells within the area.
sing consecutive sections from three different areas (a–c in E).
bryos. Asterisksmark the cardinal vein (CV) and the black arrowheads indicate
Sections are stained with antisera to Lyve1 (red) and Endomucin (green). White
a Pkd2/ E14.5 embryo. Scale bars represent 100 mm.
Prox1 (red) showing lymphovenous valves (arrowheads) between the JLS and
a a, b, or c in Figure S2A. Results in (F), (G), and (O)–(R) are presented as the
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Figure 4. Migration Defects in PKD1- and PKD2-Depleted LECs
(A) Representative images from wound-healing assays performed with hLECs transfected with lentiviral shRNAs against PKD1 (20DPC1 or 22DPC1), PKD2
(16DPC2 or 17DPC2), or empty vector. Confluent monolayers were photographed at the indicated times after wounding. Dotted lines indicate the border of the
wound. Scale bar represents 100 mm.
(B) Quantification of wound healing. The percentage of wound healed was calculated by comparing the area of the wound at T20 to T0. Each experiment was
performed in triplicate and wound healing was calculated in 12 fields/experiment.
(C) Monolayers were stained for Ki67 at T20 and the positive nuclei were counted (ten fields/experiment).
(D) Boyden chamber assay with LECs transfected with lentiviral shRNAs. Experiments were performed in triplicate, with ten fields counted per sample.
(legend continued on next page)
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Tie2-Cre-directed EC deletion of Pkd1 or Pkd2 (Garcia-
Gonzalez et al., 2010). We were able to model this defect
in vitro using PC-depleted lymphatic ECs in a 3D Matrigel cul-
ture assay. In addition, we found that the pattern of directed
migration that LECs undertake as they move away from the
cardinal vein en route to establishing the first lymphatic vessels
was disrupted in Pkd1- and Pkd2-null animals. Our data
demonstrating that Pkd1 and Pkd2 mutants have an identical
phenotype are confirmatory and are consistent with a wealth
of data showing that these two proteins directly interact and
cooperate in a common signaling pathway (Gallagher et al.,
2010; Qian et al., 1997).
Wewere also able to exclude other possible causes of edema.
We analyzed cardiac morphology in a set of edematous Pkd1/
mice and failed to identify the structural cardiac defects that
have been reported in some Pkd mouse models. In addition,
although Tie2-Cre-directed deletion of Pkd2 that largely spares
the lymphatic vasculature results in diminished complexity of
the dermal capillary network, the animals were not edematous.
Therefore, we conclude that these other phenotypes (cardiac
and nonlymphatic capillary defects) are independent and are
not the primary cause of edema.
Our findings are in line with the data of Coxam et al. (2014)
described in this issue of Cell Reports. These investigators
carried out a forward genetic screen for lymphatic mutants in
zebrafish and identified Pkd1a as a gene required for lymphatic
vessel development. Together, our results suggest that edema
in Pkd mutants is due to a lymphatic defect.
The specific lymphatic phenotype of Pkd mutant embryos
prompted us to speculate that PCs might play an important
role in regulating the directional migration of LECs. We tested
this hypothesis using in vitro migration assays, and we demon-
strated that ECs (both LECs and HUVECs) depleted of PC1 or
PC2 had a defect in establishing front-rear polarity in response
to a wound and therefore failed to migrate in a directional
manner. PC signaling may play a generalized role in oriented
cell movements, since Castelli et al. (2013) recently demon-
strated that Pkd1/ mouse embryonic fibroblasts also failed
to establish front-rear asymmetry in wound-healing assays.
These authors proposed that a direct interaction between PC1
and PAR3 favors the formation of a propolarity complex. Addi-
tional studies will be necessary to determine whether this is
also the case for ECs and how PC2 fits into this model.
We previously reported that deletion of Pkd1 or Pkd2 in ECs
using a Tie2-Cre recombinase did not result in an edematous
phenotype (Garcia-Gonzalez et al., 2010). Here, we revisited(E) Tracking of individual cells by time-lapse videomicroscopy. LECswere transfe
200min. Each line represents the trajectory of an individual cell. The colored dots i
after 200 min.
(F–H) Quantification of migration parameters. The accumulated distance travele
distance between the start and end points of migration (G). The directionality in
comparing the Euclidean and accumulated distances (H). Each experiment was p
(I–K) Golgi orientation during migration. LEC monolayers were wounded and all
marker GM 130 (red), and DAPI (blue). Representative images are shown in (J). Th
direction of migration as determined by Golgi localization. Scale bar represents 25
the 120 forward sector was calculated (I and K). Each experiment was performed
in (B)–(D), (F)–(H), and (K) are presented as the mean ± SEM; *p < 0.05, **p < 0.0
See also Figures S3 and S4, and Movies S1, S2, S3, and S4.that issue with a focus on the lymphatic system and
found that the Tie2-Cre recombinase has patchy, variable
activity that seems to largely spare LECs, as evidenced by a
normal lymphatic capillary network in Pkd2endo embryos.
This provides one plausible explanation for the lack of edema
in these animals. We cannot exclude the possibility that dele-
tion of PCs in multiple cell types, including LECs, interstitial
cells, and/or pericytes, is required for the full-blown edematous
phenotype that is observed in null animals. Further studies will
be required to determine what cell types might combine to yield
the full vascular phenotype observed in germline Pkd knockout
embryos.
In summary, our data identify the PKD1-PKD2 signaling
pathway as a player in lymphatic development. Our results
suggest that the basis for the lymphatic defect in Pkd mutant
animals is the requirement for PCs in cell polarization and
directed migration, a process that is essential at several steps
in lymphatic morphogenesis.
EXPERIMENTAL PROCEDURES
Animals
The Pkd1- and Pkd2-targeted alleles and genotyping procedures used were
described previously (Garcia-Gonzalez et al., 2010; Piontek et al., 2004). All
Pkd alleles were maintained in a C57BL/6 background. Pkd2endo mice had
the genotype Pkd2cond/cond; Tie2-Cre+. Pkd2endo+ mice had the genotype
Pkd2cond/+;Tie2-Cre or Pkd2 cond/cond; Tie2-Cre. The mT/mG double-fluo-
rescent reporter (Jax Mice 007676) and the Tie2-Cre recombinase lines were
described previously (Kisanuki et al., 2001; Muzumdar et al., 2007). For timed
matings, the day of the vaginal plug was considered to be E0.5. The Johns
Hopkins School of Medicine and the University of Maryland School of Medi-
cine animal care and use committees approved the animal protocols.
Micro-CT and Cardiac Pathology
E14.5 embryos were harvested and fixed in 4% formaldehyde. Three em-
bryos of each genotype, stained with a proprietary contrast agent, were
scanned at Numira Biosciences on a high-resolution mCT40 scanner (Scanco
Medical AG). The image data were acquired at 6 mm resolution and the
DICOM files were examined using AltaViewer (Numira). For segmentation
and reconstruction of the hearts and peripheral vessels, raw data files
were converted into a file format compatible with the segmentation software
VHLab (Numira). A cardiac pathologist (M.K.H.) blinded to genotype
measured the wall thickness in three to four sections per sample. Valves
were used as a reference.
Whole-Mount Immunofluorescence of Skin
Skin was dissected and fixed in 4% paraformaldehyde (PFA), washed in PBS,
dehydrated in methanol, and rehydrated in PBS. After blocking (1% BSA, 5%
fetal bovine serum [FBS], and 0.1% Triton X-100), the tissue was incubated
with anti-Lyve1 (1:200) and anti-Endomucin (1:50) at 4C overnight. Thectedwith lentiviral shRNAs as in (A). Monolayers weremonitored every 5min for
ndicate cells that traveled at least 25 mm (red dotted line) in the forward direction
d was calculated by summing all cell paths (F). The Euclidean distance is the
dex is a measure of the directness of the cell trajectory and is calculated by
erformed four times and a minimum of 80 cells per experiment were analyzed.
owed to migrate for 5 hr. Cells were labeled with Phalloidin (green), the Golgi
e white dotted line delimits the front of migration, and white arrows indicate the
mm. The percentage of cells at the migrating front that reoriented their Golgi to
in triplicate and aminimum of 200 cells per experiment were analyzed. Results
1, ***p < 0.001; NS, not significant.
Cell Reports 7, 634–644, May 8, 2014 ª2014 The Authors 641
Figure 5. Capillary Network Defects in Pkd2 Mutant Embryos
(A–C) Whole mount of dorsal skin from E14.5 Pkd2/, Pkd2endo, and control embryos stained with anti-Endomucin. Panels (A) and (B) are montages of four
microscopic fields (2 mm 3 2 mm). Scale bar represents 200 mm.
(A’–C’) Enlarged views from (A)–(C). Scale bars represent 50 mm.
(D–F) Quantification of vessel length (D), branch points (E), and vessel density (F) in Pkd2/ versus littermate controls.
(G–I) Quantification of vessel length (G), branch points (H), and vessel density (I) in Pkd2endo versus littermate controls.
(legend continued on next page)
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samples were washed in PBT (PBS with 1% Triton X-100) and incubated with
the appropriate secondary antibody. The tissue was imaged with a confocal
laser scanning microscope (LSM 510; Carl Zeiss) mounted on an Axioplan
microscope (Zeiss). For lymphatic capillaries, quantification was performed
with ImageJ (NIH) in ten randomly selected, nonoverlapping microscopic
fields. For other capillary beds, quantification was performed in ten randomly
selected, nonoverlapping microscopic fields using AngioTool (Zudaire et al.,
2011).
Analysis of JLS
Embryos were fixed in 4% PFA, washed in PBS, and then oriented in paraffin
blocks so that transverse sections could be cut. Sections were washed in PBS
and incubated overnight at 4C with primary antibodies diluted in blocking
solution (3% FBS, 1% BSA, and 0.1% Triton X-100 in PBS). The relative
area of the JLS was calculated as previously described (Fritz-Six et al.,
2008). Three different regions containing the JLS were selected by referencing
internal anatomical structures. At least four sections per region were assayed
using ImageJ software. The budding area of Prox1+ cells was calculated in a
blinded fashion using Prox1/Endomucin-stained sections as previously
described (D’Amico et al., 2009). Six to ten sections per animal per area
were analyzed with ImageJ software. The relative budding area was normal-
ized to the number of Prox1+ cells lying within the area.
In Vitro Endothelial Tube Formation Assay
Ninety-six-well plates were coated with 75 ml per well of undilutedMatrigel (BD
PharMingen) and allowed to gel (30 min at 37C). Lentiviral-infected ECs were
serum deprived overnight, trypsinized, and resuspended in basal media
(EBM). After counting, 2 3 104 cells per well were seeded and overlaid with
EBM supplemented with1% FBS and 200 ng/mL VEGF-C for 18 hr to allow
capillary-like formation. Structures were fixed with 4% PFA and stained using
phalloidin and DAPI. Photographs of at least three representative areas per
well were taken in triplicates of four experiments per shRNA.
Wound-Healing Assays and Time-Lapse Microscopy
Cells were transduced with lentivirus (see also Supplemental Experimental
Procedures). Confluent monolayers were serum starved overnight and the
monolayer was wounded with a pipette tip. The area of the cell-free wound
was recorded at the indicated time points using an inverted microscope
(Axiovert D1; Zeiss). The captured images were analyzed using ImageJ
analysis software. At the end of each experiment (T = 20 hr), cells were
fixed and stained with anti-Ki67 and DAPI. The number of positive nuclei
per area was calculated in ten fields per condition. The percentage of
healing was calculated by subtracting the area of the wound at different
time points from the initial wound area. Each virus transfection was per-
formed in triplicate and then used to perform experiments in triplicate.
Wound healing was calculated at 103 magnification in a total of 12 fields
per condition.
For time-lapse studies, ECs were seeded at equal density onto glass
chamber slides and kept in a temperature/humidity/CO2-regulated chamber.
Video recording was started 1 hr after monolayers were wounded. At least
seven microscope fields per well were taken every 5 min for a minimum of
200 min. Images were acquired with a plan objective 103 air in a 3i Maria-
nis/Yokogawa spinning-disk confocal microscope. Cell motility was tracked
using the manual-tracking tool from ImageJ, setting the nucleus of the cell
as a centroid. Data were analyzed using the Chemotaxis and Migration Tool
Software (Ibidi; http://ibidi.com) and cell trajectories were determined from
three to four independent experiments. The accumulated distance was calcu-
lated as the sum of all movements between all the frames for each individual
cell (total 48 per cell). The Euclidean distance represents the length of the
straight line between the starting frame (T0) and the end point (T200 for(J and K) Whole mount of dorsal skin from Pkd2endo; mT/mG+, and control (P
persistent mTomato expression in Lyve1+ LECs, indicating lack of Tie2-Cre recom
fluorescence in Pkd2endomice. n = 3 animals of each genotype analyzed. Scale
0.05, **p < 0.01.
See also Figures S5 and S6.LECs, T240 for EA.hy926). Directionality (the directness of the cell trajectory)
was calculated using the following formula:
D=Distance
Euclidean
Accumulated
:
Statistical Analysis
Student’s t test was used to calculate statistical significance between two
experimental groups. ANOVA was used to calculate statistical significance
between more than two experimental groups. All data are represented as
mean ± SEM.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and four movies and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2014.03.064.
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